معرفی
Harald Mischak is a Visiting Professor at the University of Glasgow's School of Cardiovascular & Metabolic Health. His research focuses on proteomics and biomarker development, particularly in cardiovascular and kidney diseases. He leads studies like HOMAGE and African-PREDICT, exploring urinary peptides as diagnostic tools for conditions such as heart failure, hypertension, and diabetic nephropathy. Collaborations with institutions worldwide emphasize translational research, aiming to bridge proteomic discoveries with clinical applications.
Research interests include non-invasive diagnostics, biomarker validation, and integrative omics for personalized medicine. Key contributions involve identifying urinary proteomic signatures for diseases like prostate cancer and cardiac allograft vasculopathy. His work highlights the utility of capillary electrophoresis-mass spectrometry (CE-MS) in clinical settings.
Publications span biomarker validation in kidney disease, cardiovascular risk profiling, and oncology. His lab at the British Heart Foundation Glasgow Cardiovascular Research Centre (Bhf Gcrc) drives interdisciplinary projects, emphasizing clinical implementation of proteomic findings.